Tim D.D. Somerville
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Hematology 11
- Acute Myeloid Leukemia Research 11
-
- Epigenetics and DNA Methylation 9
- Protein Degradation and Inhibitors 7
- Histone Deacetylase Inhibitors Research 4
- Genomics and Chromatin Dynamics 3
- Co-authors
- Christopher R. Vakoc (8 shared papers)Joseph P. Milazzo (4 shared papers)Tim C. P. Somervaille (9 shared papers)Yali Xu (3 shared papers)Gary J. Spencer (6 shared papers)Diogo Maia-Silva (3 shared papers)Xu Huang (5 shared papers)David Arthur Tuveson (2 shared papers)
- Journals
- Cancer Cell (5 papers)Cancer Discovery (2 papers)Cell Reports (2 papers)Leukemia (2 papers)Cell Death and Disease (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Tim D.D. Somerville
22 papers receiving 2.2k citations
Tim D.D. Somerville's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 1.1k
- Cancer Research 616
- Molecular Biology 1.1k
- Hematology 144
- Immunology 165
Countries citing papers authored by Tim D.D. Somerville
This map shows the geographic impact of Tim D.D. Somerville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim D.D. Somerville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim D.D. Somerville more than expected).
Fields of papers citing papers by Tim D.D. Somerville
This network shows the impact of papers produced by Tim D.D. Somerville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim D.D. Somerville. The network helps show where Tim D.D. Somerville may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim D.D. Somerville, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer Hit paper breakdown → | 2018 | 838 |
| 2 | Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis Hit paper breakdown → | 2017 | 359 |
| 3 | 2018 | 157 | |
| 4 | 2018 | 110 | |
| 5 | 2020 | 100 | |
| 6 | 2020 | 90 | |
| 7 | 2014 | 74 | |
| 8 | 2020 | 74 | |
| 9 | 2018 | 62 | |
| 10 | 2015 | 61 | |
| 11 | 2022 | 54 | |
| 12 | 2018 | 48 | |
| 13 | 2020 | 46 | |
| 14 | 2013 | 43 | |
| 15 | 2013 | 34 | |
| 16 | 2024 | 32 | |
| 17 | 2018 | 23 | |
| 18 | 2016 | 13 | |
| 19 | 2013 | 10 | |
| 20 | 2024 | 6 |
About Tim D.D. Somerville
Tim D.D. Somerville is a scholar working on Hematology, Molecular Biology, Oncology, Cancer Research and Genetics, having authored 23 papers that have together received 2.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Epigenetics and DNA Methylation (9 papers), Protein Degradation and Inhibitors (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer Genomics and Diagnostics (3 papers), Genomics and Chromatin Dynamics (3 papers) and Pancreatic function and diabetes (2 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (616 citations), Molecular Biology (1.1k citations), Hematology (144 citations) and Immunology (165 citations). Tim D.D. Somerville has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Christopher R. Vakoc, Joseph P. Milazzo, Tim C. P. Somervaille, Yali Xu, Gary J. Spencer, Diogo Maia-Silva, Xu Huang, David Arthur Tuveson, Koji Miyabayashi and Xiaoli Wu. Their work appears in journals such as Cancer Cell, Cancer Discovery, Cell Reports, Leukemia and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.